<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The neuroprotective effects of the <z:chebi fb="0" ids="33309">noble gas</z:chebi> <z:chebi fb="3" ids="49957">xenon</z:chebi> are well known </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="17" ids="49474,49475">Argon</z:chebi>, in contrast to <z:chebi fb="3" ids="49957">xenon</z:chebi>, is abundant, inexpensive, and therefore widely applicable </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we analyzed the possible neuroprotective role of <z:chebi fb="17" ids="49474,49475">argon</z:chebi> in an in vivo rat model of <z:hpo ids='HP_0011009'>acute</z:hpo> focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: Controlled laboratory study </plain></SENT>
<SENT sid="4" pm="."><plain>SETTING: Academic research laboratory </plain></SENT>
<SENT sid="5" pm="."><plain>SUBJECTS: Male adult Sprague-Dawley rats </plain></SENT>
<SENT sid="6" pm="."><plain>INTERVENTIONS: Twenty-two rats underwent 2 hrs of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> using the endoluminal thread model </plain></SENT>
<SENT sid="7" pm="."><plain>One hr after transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> induction, spontaneously breathing rats received either 50 vol % <z:chebi fb="17" ids="49474,49475">argon</z:chebi>/50 vol % O2 (<z:chebi fb="17" ids="49474,49475">argon</z:chebi> group, n = 11) or 50 vol % N2/50 vol % O2 (control group, n = 11) for 1 hr through a face mask </plain></SENT>
<SENT sid="8" pm="."><plain>Twenty-four hrs after reperfusion, rats were neurologically and behaviorally tested and euthanized </plain></SENT>
<SENT sid="9" pm="."><plain>Rat brains were stained with 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> and <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes determined by planimetry </plain></SENT>
<SENT sid="10" pm="."><plain>MEASUREMENTS AND MAIN RESULTS: After 2 hrs of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in the rat, we found in the <z:chebi fb="17" ids="49474,49475">argon</z:chebi> group a significant reduction in the overall (p = .004) and after subdivision in the cortical (p = .007) and the basal ganglia (p = .02) <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="17" ids="49474,49475">Argon</z:chebi> treatment resulted in a significant improvement of the composite adverse outcome (p = .034) </plain></SENT>
<SENT sid="12" pm="."><plain>However, there was no advantage in <z:hpo ids='HP_0011009'>acute</z:hpo> survival 24 hrs after transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (p = .361) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: We were able to demonstrate <z:chebi fb="17" ids="49474,49475">argon</z:chebi>'s neuroprotective effects in an in vivo experimental rat model of <z:hpo ids='HP_0011009'>acute</z:hpo> focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>Animals breathing spontaneously 50 vol % <z:chebi fb="17" ids="49474,49475">argon</z:chebi> 1 hr after induction of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 1 hr by face mask showed significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes and composite adverse outcomes </plain></SENT>
</text></document>